Outcome of patients receiving thrombolytic therapy while on Rivaroxaban for nonvalvular atrial fibrillation (from Rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017
|
| In: |
The American journal of cardiology
Year: 2017, Volume: 120, Issue: 102, Pages: 1837-1840 |
| ISSN: | 1879-1913 |
| Online Access: | Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0002914917313012?via%3Dihub
|
| Author Notes: | Sean T. Chen, Anne S. Hellkamp, Richard C. Becker, Scott D.Berkowitz, Günter Breithardt, Keith A.A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Kenneth W. Mahaffey, Christopher C. Nessel, Jonathan P. Piccini, Daniel E. Singer and Manesh R. Patel |
| Item Description: | Gesehen am: 23.10.2017 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1879-1913 |